Growth Stocks

Prompted by Obamacare’s strictures, the dominant carriers in California are exiting the state’s individual health insurance market. Here’s what it all means for the health care industry in the Golden State. Read More

  • June 28, 2013

Its dramatic price decline, accompanied by extremely negative commentary, makes the "store of value" worth a new look. Read More

Although the drugmaker’s treatment for hepatitis C has shown great promise during clinical trials, investors still have time to take advantage of this stock before shares head higher in anticipation of the drug’s approval. Read More